Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1972 7
1973 15
1974 5
1975 11
1976 13
1977 8
1978 5
1979 10
1980 21
1981 10
1982 12
1983 15
1984 18
1985 13
1986 13
1987 25
1988 29
1989 19
1990 26
1991 28
1992 25
1993 34
1994 30
1995 25
1996 30
1997 35
1998 21
1999 30
2000 25
2001 21
2002 19
2003 34
2004 23
2005 32
2006 31
2007 31
2008 31
2009 31
2010 36
2011 46
2012 58
2013 56
2014 51
2015 44
2016 40
2017 35
2018 31
2019 30
2020 30
2021 40
2022 6
Text availability
Article attribute
Article type
Publication date

Search Results

1,221 results
Results by year
Filters applied: . Clear all
Page 1
Effects of metformin versus glipizide on cardiovascular outcomes in patients with type 2 diabetes and coronary artery disease.
Hong J, Zhang Y, Lai S, Lv A, Su Q, Dong Y, Zhou Z, Tang W, Zhao J, Cui L, Zou D, Wang D, Li H, Liu C, Wu G, Shen J, Zhu D, Wang W, Shen W, Ning G; SPREAD-DIMCAD Investigators. Hong J, et al. Diabetes Care. 2013 May;36(5):1304-11. doi: 10.2337/dc12-0719. Epub 2012 Dec 10. Diabetes Care. 2013. PMID: 23230096 Free PMC article. Clinical Trial.
RESULTS: At the end of study drug administration, both groups achieved a significant decrease in the level of glycated hemoglobin (7.1% in the glipizide group and 7.0% in the metformin group). At a median follow-up of 5.0 years, 91 participants had developed 103 primary en …
RESULTS: At the end of study drug administration, both groups achieved a significant decrease in the level of glycated hemoglobin (7.1% in t …
Dapagliflozin versus glipizide as add-on therapy in patients with type 2 diabetes who have inadequate glycemic control with metformin: a randomized, 52-week, double-blind, active-controlled noninferiority trial.
Nauck MA, Del Prato S, Meier JJ, Durán-García S, Rohwedder K, Elze M, Parikh SJ. Nauck MA, et al. Diabetes Care. 2011 Sep;34(9):2015-22. doi: 10.2337/dc11-0606. Epub 2011 Aug 4. Diabetes Care. 2011. PMID: 21816980 Free PMC article. Clinical Trial.
We compared the efficacy, safety, and tolerability of dapagliflozin with the sulfonylurea glipizide in patients with type 2 diabetes inadequately controlled with metformin monotherapy. ...RESULTS: The primary end point, adjusted mean HbA(1c) reduction with dapagliflozin (- …
We compared the efficacy, safety, and tolerability of dapagliflozin with the sulfonylurea glipizide in patients with type 2 diabetes …
Glyburide and glipizide, second-generation oral sulfonylurea hypoglycemic agents.
Prendergast BD. Prendergast BD. Clin Pharm. 1984 Sep-Oct;3(5):473-85. Clin Pharm. 1984. PMID: 6435940 Review.
Glyburide and glipizide are well absorbed after oral administration. The absorption of glipizide is delayed by food; in contrast, glyburide absorption does not seem to be affected by administration with meals. ...Glyburide and glipizide appear to be comparabl …
Glyburide and glipizide are well absorbed after oral administration. The absorption of glipizide is delayed by food; in contra …
Glipizide. A review of the pharmacoeconomic implications of the extended-release formulation in type 2 diabetes mellitus.
Foster RH, Plosker GL. Foster RH, et al. Pharmacoeconomics. 2000 Sep;18(3):289-306. doi: 10.2165/00019053-200018030-00008. Pharmacoeconomics. 2000. PMID: 11147395 Review.
In patients with type 2 diabetes mellitus, glipizide GITS is at least as effective as the immediate-release formulation of glipizide in providing glycaemic control, and may have a greater effect on fasting plasma glucose levels. ...There are limitations to the prese …
In patients with type 2 diabetes mellitus, glipizide GITS is at least as effective as the immediate-release formulation of glipizi
[Pharmacokinetics of hypoglycemic sulfonamides: Ozidia, a new concept].
Selam JL. Selam JL. Diabetes Metab. 1997 Nov;23 Suppl 4:39-43. Diabetes Metab. 1997. PMID: 9463023 Review. French.

The action period for "short-term" sulfonamides is < or = 24 h (tolbutamide, glipizide) and can exceed 24 h for "long-term" sulfonamides (e.g. glibenclamide). ...It controls fasting glycaema better than ordinary glipizide and at least as well as glibenclamide by

The action period for "short-term" sulfonamides is < or = 24 h (tolbutamide, glipizide) and can exceed 24 h for "long-term" sulfon

Use of hypoglycemic drugs during lactation.
Glatstein MM, Djokanovic N, Garcia-Bournissen F, Finkelstein Y, Koren G. Glatstein MM, et al. Can Fam Physician. 2009 Apr;55(4):371-3. Can Fam Physician. 2009. PMID: 19366943 Free PMC article. Review.
QUESTION: My patient was taking glipizide (an oral sulfonylurea) for type 2 diabetes. Now she is pregnant and taking insulin instead. ...ANSWER: The exposure of infants to second-generation sulfonylureas (eg, glipizide, glyburide) through breast milk is expected to …
QUESTION: My patient was taking glipizide (an oral sulfonylurea) for type 2 diabetes. Now she is pregnant and taking insulin instead. …
Stable Co-crystals of Glipizide with Enhanced Dissolution Profiles: Preparation and Characterization.
Pandey NK, Sehal HR, Garg V, Gaur T, Kumar B, Singh SK, Gulati M, Gowthamarajan K, Bawa P, Rajesh SY, Sharma P, Narang R. Pandey NK, et al. AAPS PharmSciTech. 2017 Oct;18(7):2454-2465. doi: 10.1208/s12249-017-0727-z. Epub 2017 Feb 7. AAPS PharmSciTech. 2017. PMID: 28176212
PXRD further revealed that all the co-crystals were having similar crystallinity as that of raw glipizide except glipizide-malonic acid co-crystals. This minor difference in the relative intensities of some of the diffraction peaks could be attributed to the crystal …
PXRD further revealed that all the co-crystals were having similar crystallinity as that of raw glipizide except glipizide-mal …
The Physico-Chemical Properties of Glipizide: New Findings.
Bruni G, Ghione I, Berbenni V, Cardini A, Capsoni D, Girella A, Milanese C, Marini A. Bruni G, et al. Molecules. 2021 May 24;26(11):3142. doi: 10.3390/molecules26113142. Molecules. 2021. PMID: 34073973 Free PMC article.
Hence, our results put into evidence that the check of the polymorphic form of glipizide cannot be based on the temperature values of the DSC peak, since such a peak is due to a decomposition process whose Tonset value is strongly affected by the particle size. Kinetic stu …
Hence, our results put into evidence that the check of the polymorphic form of glipizide cannot be based on the temperature values of …
Glipizide blocks renal interstitial fibrosis by inhibiting AKT signaling pathway.
Yang G, Zeng G, Wu JP, Jiang O, Zeng YB, Huang SJ, Huang JJ, Wu DQ. Yang G, et al. Eur Rev Med Pharmacol Sci. 2017 Feb;21(4):867-872. Eur Rev Med Pharmacol Sci. 2017. PMID: 28272693 Free article.
OBJECTIVE: Diabetes affects the renal function at a certain stage. Oral medication glipizide plays a hypoglycemic effect mainly through releasing insulin, while more insulin is derived from islet beta cells. ...Western blot revealed that p-AKT expression downregulated afte …
OBJECTIVE: Diabetes affects the renal function at a certain stage. Oral medication glipizide plays a hypoglycemic effect mainly throu …
1,221 results